DK1011717T3 - Arginin-deiminase afledt af mycoplasma-arthritidis og polymere konjugater indeholdende dette - Google Patents

Arginin-deiminase afledt af mycoplasma-arthritidis og polymere konjugater indeholdende dette

Info

Publication number
DK1011717T3
DK1011717T3 DK98903799T DK98903799T DK1011717T3 DK 1011717 T3 DK1011717 T3 DK 1011717T3 DK 98903799 T DK98903799 T DK 98903799T DK 98903799 T DK98903799 T DK 98903799T DK 1011717 T3 DK1011717 T3 DK 1011717T3
Authority
DK
Denmark
Prior art keywords
arginine deiminase
adi
mycoplasma arthritidis
seq
expressing
Prior art date
Application number
DK98903799T
Other languages
Danish (da)
English (en)
Inventor
Maoling Wang
David Ray Filpula
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Inc filed Critical Enzon Inc
Application granted granted Critical
Publication of DK1011717T3 publication Critical patent/DK1011717T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/50Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK98903799T 1997-01-31 1998-01-27 Arginin-deiminase afledt af mycoplasma-arthritidis og polymere konjugater indeholdende dette DK1011717T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/792,283 US5804183A (en) 1997-01-31 1997-01-31 Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same

Publications (1)

Publication Number Publication Date
DK1011717T3 true DK1011717T3 (da) 2006-05-15

Family

ID=25156365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98903799T DK1011717T3 (da) 1997-01-31 1998-01-27 Arginin-deiminase afledt af mycoplasma-arthritidis og polymere konjugater indeholdende dette

Country Status (9)

Country Link
US (3) US5804183A (https=)
EP (1) EP1011717B1 (https=)
JP (1) JP4126097B2 (https=)
AT (1) ATE314086T1 (https=)
AU (1) AU6047598A (https=)
DE (1) DE69832993T2 (https=)
DK (1) DK1011717T3 (https=)
ES (1) ES2255147T3 (https=)
WO (1) WO1998033519A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635462B1 (en) * 1997-05-12 2003-10-21 Phoenix Pharmacologies, Inc. Mutated form of arginine deiminase
US6183738B1 (en) * 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
KR20040004449A (ko) * 2000-11-28 2004-01-13 휘닉스 파머컬러직스, 인크. 변형된 아르기닌 데이미나제
US6645739B2 (en) * 2001-07-26 2003-11-11 Phoenix Pharmacologies, Inc. Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
WO2004046309A2 (en) * 2002-11-18 2004-06-03 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
FR2884717B1 (fr) * 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
JP5313129B2 (ja) 2006-05-02 2013-10-09 アロザイン, インコーポレイテッド 非天然アミノ酸置換ポリペプチド
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
JP2009044997A (ja) * 2007-08-20 2009-03-05 Sony Corp ビリルビンオキシダーゼ(bod)の被覆方法
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
EP2295560A1 (en) 2009-09-14 2011-03-16 RWTH Aachen University Directed evolution of arginine deiminase for increased activity at physiological pH
US9255262B2 (en) * 2013-03-06 2016-02-09 Vision Global Holdings Ltd. Albumin-binding arginine deminase and the use thereof
USRE48805E1 (en) 2013-03-06 2021-11-02 Vision Global Holdings Ltd. Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
WO2014151982A2 (en) 2013-03-15 2014-09-25 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi – peg 20 antibodies for cancer treatment
WO2015143006A1 (en) * 2014-03-18 2015-09-24 Tdw Group Engineered chimeric pegylated adi and methods of use
EP4104853B1 (en) 2014-09-16 2026-05-06 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
EP3344575B1 (en) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
CA3023092A1 (en) 2016-05-03 2017-11-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
CN119950689A (zh) 2016-07-05 2025-05-09 北极星药业集团股份有限公司 使用精氨酸耗竭剂的组合癌症免疫疗法
TWI784982B (zh) 2016-11-02 2022-12-01 開曼群島商北極星藥業集團股份有限公司 聚乙二醇化精胺酸脫亞胺酶之調配物
KR20220150408A (ko) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
WO2018183671A1 (en) 2017-03-29 2018-10-04 Tdw Group Protein conjugates
WO2019042628A1 (en) 2017-08-31 2019-03-07 Erytech Pharma ARGININE DEIMINASE ENCAPSULATED WITHIN ERYTHROCYTES AND THEIR USE IN THE TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY
EP3449935A1 (en) 2017-08-31 2019-03-06 Erytech Pharma Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency
KR20220053575A (ko) * 2019-08-01 2022-04-29 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 항체 결합 및 중화 항체 억제를 위한 조성물 및 방법
CA3128035A1 (en) 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Combination therapies for delivery across the blood brain barrier
EP4288445A1 (en) * 2021-02-03 2023-12-13 The University of North Carolina at Chapel Hill Protein m analogs and fusion proteins and their use for inhibiting antibody function
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPH0253490A (ja) * 1988-08-16 1990-02-22 Agency Of Ind Science & Technol アルギニン・デイミナーゼ遺伝子
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
JP2900279B2 (ja) * 1989-08-02 1999-06-02 株式会社ジャパンエナジー 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤
JP3209338B2 (ja) * 1990-09-10 2001-09-17 株式会社ジャパンエナジー ポリエチレングリコール修飾アルギニンデイミナーゼおよびその製造法
US5372942A (en) * 1992-02-10 1994-12-13 Coriell Institute For Medical Research Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same

Also Published As

Publication number Publication date
US5916793A (en) 1999-06-29
ATE314086T1 (de) 2006-01-15
DE69832993D1 (de) 2006-02-02
EP1011717B1 (en) 2005-12-28
EP1011717A1 (en) 2000-06-28
US6132713A (en) 2000-10-17
EP1011717A4 (en) 2003-02-19
JP4126097B2 (ja) 2008-07-30
ES2255147T3 (es) 2006-06-16
DE69832993T2 (de) 2006-09-07
JP2001512965A (ja) 2001-08-28
WO1998033519A1 (en) 1998-08-06
AU6047598A (en) 1998-08-25
US5804183A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
DK1011717T3 (da) Arginin-deiminase afledt af mycoplasma-arthritidis og polymere konjugater indeholdende dette
DK1025211T3 (da) Hyaluronansyntasegen og anvendelser deraf
KR960031608A (ko) 바실러스-유래 트랜스글루타미나제
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
TR200500004T2 (tr) Karbon metabolizma ve enerji üretimindeki proteinleri dodlayan korynebacterium glutamicum genleri
BR9804896A (pt) Dna isolado e purificado, célula hospedeira, vetor, polinucleotídeo quimérico, plasmídeo e processo para aumentar a transcrição de um gene de interesse em uma célula hospedeira
TR200607443T1 (tr) Membran sentezi ve membran nakli dahilinde corynebacterium glutamicum kodlayan proteinler
BR9913360B1 (pt) proteÍna de uricase recombinante quimÉrica, molÉcula de Ácido nuclÉico isolada e purificada, vetor e cÉlula hospedeira transformada.
DE69131580D1 (de) GDF-1 und UOG1 Proteine
BR0010114A (pt) Vetor biologicamente funcional, molécula de dna, molécula de dna codificada para ribozima, método de clonagem de uma transferase g1cnac-a-1.3-fucosil, método de preparação de células hospedeiras recombinantes, células de plantas recombinantes, insetos ou células de insetos recombinantes, molécula de ácido nucléico de peptìdeo (pna), método de produção de plantas ou insetos ou células, método de produção de glicoproteìnas recombinantes, método de produção de glicoproteìnas humanas, recombinantes, método de produção de gligoproteìnas humanas, recombinantes para uso médico, método de seleção de moléculas de dna codificada para uma transferase g1cnac-a-1,-3-fucosil em uma amostra
BR9909346A (pt) Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico
TR200700067T2 (tr) Corynebacterium glutamicum gen kodlayıcı fosfoenol piruvat : şeker fosfotransferaz sistem proteini
ATE327321T1 (de) Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden
Greaser et al. cDNA sequence of rabbit cardiac titin/connectin
TR200700070T2 (tr) Corynebacterİum glutamicum gen kodlayıcı fosfoenol piruvat şeker fosfotransferaz sistem proteini.
DE69942611D1 (de) Schützende hochmolekulargewichtsproteine aus haemophilus influenzae
CA2405268A1 (en) Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus
TR200707453T2 (tr) Karbon metabolizma ve enerji üretimindeki proteinleri kodlayan corynebacterıum glutamicum genleri.
WO2003050302A3 (en) Tgnp activity or expression as marker for apoptosis
RU94032791A (ru) Фрагменты днк, рекомбинантная плазмидная днк и способ получения нитрил-гидратазы
WO2003054010A3 (en) Early stage redox-related apoptosis modulator-2 (esram-2)
WO2003048361A3 (en) P55pik
TR200500278T1 (tr) Membran sentezi ve membran nakli dahilinde corynebacterıum glutamıcum kodlayan proteinler
BR0011803A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, polipeptìdeo e métodos para produzir um polipeptìdeo e um produto quìmico fino e para diagnosticar a presença ou atividade de corynebacterium diphtheriae em um paciente